Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer
Clinical trial NCT06519669 · TERMINATED
Trial details
- NCT number
- NCT06519669
- Sponsor
- Grit Biotechnology
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-18
- Primary completion
- 2025-12-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.